Drugs (red spots) don’t get into peripheral nerves when the barrier is closed (left-side image) – only when the barrier is opened (right-side image).
Image courtesy Prof Lloyd.
A UCL-led research team has opened and closed the blood-nerve barrier for the first time and used it to deliver drugs to target tissues.
The Medical Research Council and Cancer Research UK-funded research, published in Developmental Cell, has the potential to both deliver tumour-killing drugs to the nervous system, and also prevent side effects from chemotherapy that result from damage to the peripheral nervous system.
The blood-nerve barrier is less well understood than the related blood-brain barrier, which stop substances in the blood getting to the sensitive environments of the brain and peripheral nerves. They also pose a barrier for medications, so the latest study has been seeking to identify new ways to deliver drugs to the nervous system, without causing damage.
Lead author Professor Alison Lloyd, director of the UCL Laboratory for Molecular Cell Biology, explained: “We’ve defined the structure and control of the blood-nerve barrier – the cell types that are involved, how they interact, how it can be regulated and why it’s a barrier. It took more than 10 years of development, but we now have a powerful model that enables us to control and understand the opening and closing of the barrier.
“Our discovery that the barrier can be opened in a reversible manner is important in the drive to deliver drugs to the nervous system, as permanently breaking down these barriers would be toxic. We’ve shown you that can help drugs cross the barrier for a limited time, which makes side effects less likely.”
For the study, Professor Lloyd and her colleagues established the structure and function of the blood-nerve barrier, finding that it is ‘leakier’ than the blood-brain barrier, but reinforced by macrophages (a type of white blood cell) that specifically engulf leaked materials.
Using these insights, the researchers devised a way to set off a signal to open the barrier in a mouse model for enough time to deliver drugs called antisense oligonucleotides, to the peripheral nervous system.
Although at its early stages, the researchers say their paper is important for neuroscience as getting past the blood-nerve barrier could make it easier to treat a wide variety of conditions. For example, chemotherapy treatment in cancer can have an unpleasant side-effect called peripheral neuropathy, where people feel burning, tingling or numbness in their hands and feet because of damage to the peripheral nerves. This research may contribute to the development of drugs that could be added into chemotherapy treatment to minimise such side-effects.
This research also has much wider application beyond cancer. Diabetes can also cause peripheral neuropathy so the knowledge from this research could make it much easier to manage diabetes in the future. The drugs used in this study, antisense oligonucleotides, are currently in trials for diseases like Huntington’s and Duchenne muscular dystrophy, so there is potential for better care for multiple difficult-to-treat diseases.
Original Article: Unlocking the blood-nerve barrier to facilitate drug delivery
More from: University College London
The Latest Updates from Bing News
Go deeper with Bing News on:
- Top 5 Best Brain Supplements 2023- Pills for Memory, Focus, and Brain Health
The only problem is, with so many brain health supplements on the market, it can be hard to know what the best brain supplements really are. That is why we have made this list of the 5 very best brain ...
- So THAT'S Why Your Stomach Hurts More As You Get Older
As we age, the nerves and muscles in the gastrointestinal (GI ... the recommendation is seven to nine hours per night — can adversely affect your gut barrier and immunity, Mutha said. Researchers are ...
- Sciatic Nerve Injury Following Intramuscular Injection: A Case Report and Review of the Literature
with a breakdown in the blood-nerve barrier by neurotoxic chemicals in the injected agent (Gentili et al., 1980b; Villarejo & Pascual, 1993) Neurological sequelae can range from minor transient ...
- Realeve Unveils Breakthrough Solution to Treat Central Nervous System Disorders Including Stroke and Cluster Headache; Bypasses Brain’s Natural Barrier to Deliver Therapeutics
Realeve is evaluating the potential effects of its patented SPG therapy on the Blood Brain Barrier (BBB) using its clinically proven ... conditions through stimulating extra cranial nerves. By ...
- Restoring the Blood-Brain Barrier – Stanford Researchers Uncover Promising New Pathway
There's a bouncer in everyone: the blood-brain barrier, a specialized layer of cells nestled between blood vessels and the brain's delicate tissues, vigilantly ejects toxins, pathogens, and other ...
Go deeper with Bing News on:
- Global Ophthalmic Drug Delivery System Market Drivers, Restraints, Opportunities and Challenges 2023-2030
The "Global Ophthalmic Drug Delivery System Market by Technology, Production Technology, Material, Delivery Route - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - ...
- "Kexing Biopharm 2023 Innovation Forum on Targeted Drug Delivery"
On September 15, "Kexing Biopharm 2023 Innovation Forum on Targeted Drug Delivery" successfully kicked off. This marks the first time in recent years that the Company has organized an event ...
- Daring Drone Drug Delivery: Woman Drops $75K in Opioids and Porn into Aussie Prison Yard
In a jaw-dropping incident, a female drug trafficker orchestrated a drone delivery, resulting in a crash that left more than $75,000 worth of opioids and a porn-filled USB drive in an Australian ...
- Intarcia’s Diabetes Drug-Device Implant Unanimously Rejected by Adcomm
Thursday’s FDA advisory committee rejection is the latest regulatory defeat for the company’s drug-device combo. The panel found that the benefits of the treatment did not outweigh its risks.
- Hydrogel Delivery Balances Tumor’s pH, Boosts Cancer Drug’s Activity
A new hydrogel-based delivery system balances the acidic environment in a tumor and greatly enhances the cancer-fighting activity of chemotherapeutic drug.